J. Mark Ray

J. Mark Ray

Alston & Bird

Contact

Readers' Choice Awards

Healthcare
Healthcare
Healthcare
View Bio
RSS

Latest Publications

Share:

Alston & Bird Healthcare Week in Review - April 2020 #1

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

4/6/2020  /  Centers for Medicare & Medicaid Services (CMS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Personal Protective Equipment , PHSA

Alston & Bird Healthcare Week in Review - March 2020 #4

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

3/30/2020  /  CARES Act , Coronavirus/COVID-19 , DEA , Durable Medical Equipment , Food and Drug Administration (FDA) , Food Supply , Health Care Providers , Healthcare , Medical Devices , Personal Protective Equipment , Pharmaceutical Industry

Alston & Bird Healthcare Week in Review - March 2020 #3

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

3/24/2020  /  Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Families First Coronavirus Response Act (FFCRA) , Food and Drug Administration (FDA)

Alston & Bird Healthcare Week in Review - March 2020 #2

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

3/17/2020  /  Abbreviated New Drug Application (ANDA) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA)

Alston & Bird Healthcare Week in Review - March 2020 #1

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

3/9/2020  /  Biologics , Biologics Price Competition and Innovation Act of 2009 , Biosimilars , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Pharmaceutical Industry , Purple Book

Alston & Bird Healthcare Week in Review - February 2020 #4

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

3/2/2020  /  Biosimilars , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Federal Trade Commission (FTC) , HRSA

Alston & Bird Healthcare Week in Review - February 2020 #3

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

2/24/2020  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Federal Trade Commission (FTC) , Food and Drug Administration (FDA) , HRSA , Pharmacy Benefit Manager (PBM)

Alston & Bird Healthcare Week in Review - February 2020 #2

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

2/18/2020  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Federal Trade Commission (FTC) , Food and Drug Administration (FDA) , GAO , Pharmacy Benefit Manager (PBM)

Alston & Bird Healthcare Week in Review - February 2020 #1

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

2/10/2020  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HRSA , Medicare , Medicare Part D , Prescription Drugs

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

2/3/2020  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medical Devices

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

12/16/2019  /  Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , FDA Reauthorization Act , Food and Drug Administration (FDA) , GAO , Health Care Providers , Pharmaceutical Industry

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

12/9/2019  /  Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Minor Children , SAMHSA , Tobacco

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

11/25/2019  /  Abbreviated New Drug Application (ANDA) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Pharmaceutical Industry , SAMHSA

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

11/19/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

11/4/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medical Devices , Medicare , Medicare Part B , Outpatient Prospective Payment System (OPPS)

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

10/28/2019  /  Centers for Medicare & Medicaid Services (CMS) , DEA , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HRSA , Medical Devices , Pharmaceutical Industry , Prescription Drugs

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

10/21/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HRSA , Medicare , Prescription Drugs

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

10/14/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HRSA , Medical Devices , OIG , Pharmaceutical Industry , Telehealth

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

10/7/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HRSA , Medicare , Trump Administration

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/30/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medical Device User Fee Program (MDUFA IV) , Medical Devices , Medicare , Pharmaceutical Industry , Prescription Drugs

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/23/2019  /  Centers for Medicare & Medicaid Services (CMS) , Controlled Substances Act , DEA , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HRSA , Medical Devices , Pharmaceutical Industry

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/16/2019  /  Centers for Medicare & Medicaid Services (CMS) , Controlled Substances Act , DEA , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medical Device User Fee Program (MDUFA IV) , Medical Devices , Medicare , Pharmaceutical Industry , Prescription Drugs , SAMHSA

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/9/2019  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Healthcare , HRSA , Pharmaceutical Industry

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/3/2019  /  Center for Drug Evaluation and Research (CDER) , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Clinical Trials , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medical Devices , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Prescription Drugs

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

8/26/2019  /  Centers for Medicare & Medicaid Services (CMS) , Controlled Substances Act , DEA , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HRSA , Pharmaceutical Industry , SAMHSA
223 Results
 / 
View per page
« Previous
Page: of 9
Next »

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide